Delek US Holdings, Inc. (NYSE:DK - Free Report) - Equities research analysts at Zacks Research cut their Q2 2025 earnings per share estimates for shares of Delek US in a report released on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the oil and gas company will earn ($0.78) per share for the quarter, down from their prior forecast of ($0.64). The consensus estimate for Delek US's current full-year earnings is ($5.50) per share. Zacks Research also issued estimates for Delek US's Q3 2025 earnings at ($0.44) EPS, Q4 2025 earnings at ($1.29) EPS, FY2025 earnings at ($4.83) EPS, Q1 2026 earnings at ($0.90) EPS, Q2 2026 earnings at $0.01 EPS, Q3 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.44) EPS, FY2026 earnings at ($1.54) EPS, Q1 2027 earnings at ($0.19) EPS and FY2027 earnings at ($1.04) EPS.
Delek US (NYSE:DK - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.27) by ($0.05). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The business had revenue of $2.64 billion during the quarter, compared to the consensus estimate of $2.56 billion. During the same period in the previous year, the company posted ($0.41) EPS. The company's revenue for the quarter was down 18.1% compared to the same quarter last year.
Several other research analysts have also recently weighed in on the company. Morgan Stanley raised their target price on Delek US from $14.00 to $15.00 and gave the company an "underweight" rating in a research note on Monday, May 19th. The Goldman Sachs Group raised their target price on Delek US from $15.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 23rd. Scotiabank decreased their target price on Delek US from $24.00 to $14.00 and set a "sector perform" rating for the company in a research note on Friday, April 11th. Wells Fargo & Company decreased their target price on Delek US from $16.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, April 16th. Finally, Mizuho raised Delek US from a "neutral" rating to an "outperform" rating and upped their target price for the company from $22.00 to $23.00 in a report on Tuesday, May 13th. Five equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $17.27.
Read Our Latest Research Report on DK
Delek US Price Performance
DK stock traded down $0.40 during trading hours on Monday, hitting $18.86. 1,223,839 shares of the stock traded hands, compared to its average volume of 1,306,206. The stock has a 50-day simple moving average of $15.07 and a 200 day simple moving average of $16.78. Delek US has a one year low of $11.03 and a one year high of $25.83. The company has a market cap of $1.15 billion, a P/E ratio of -3.88 and a beta of 0.74. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 3.18.
Delek US Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, May 19th. Shareholders of record on Monday, May 12th were paid a $0.255 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.02 dividend on an annualized basis and a yield of 5.41%. Delek US's dividend payout ratio (DPR) is currently -9.18%.
Insiders Place Their Bets
In other news, CFO Mark Wayne Hobbs purchased 2,800 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was acquired at an average price of $13.70 per share, with a total value of $38,360.00. Following the purchase, the chief financial officer now owns 49,138 shares in the company, valued at $673,190.60. This represents a 6.04% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have bought a total of 5,055 shares of company stock valued at $70,787 in the last three months. Insiders own 1.80% of the company's stock.
Institutional Investors Weigh In On Delek US
Several large investors have recently made changes to their positions in the company. Sterling Capital Management LLC increased its holdings in shares of Delek US by 728.3% during the 4th quarter. Sterling Capital Management LLC now owns 1,491 shares of the oil and gas company's stock valued at $28,000 after acquiring an additional 1,311 shares during the last quarter. CWM LLC increased its holdings in shares of Delek US by 100.9% during the 1st quarter. CWM LLC now owns 2,318 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,164 shares during the last quarter. Creative Financial Designs Inc. ADV acquired a new position in shares of Delek US during the 1st quarter valued at about $47,000. KBC Group NV increased its holdings in shares of Delek US by 66.3% during the 4th quarter. KBC Group NV now owns 3,859 shares of the oil and gas company's stock valued at $71,000 after acquiring an additional 1,538 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Delek US by 907.0% during the 1st quarter. GAMMA Investing LLC now owns 4,159 shares of the oil and gas company's stock valued at $63,000 after acquiring an additional 3,746 shares during the last quarter. Institutional investors own 97.01% of the company's stock.
About Delek US
(
Get Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
See Also

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.